
Adar Poonawalla, the chief executive officer of the Serum Institute of India —which is licensed to produce hundreds of millions of Covid-19 vaccines from AstraZeneca and Novavax — told a World Bank panel on Thursday that a US law blocking the export of certain key items, including bags and filters, will likely cause serious bottlenecks.
from Industry-Economic Times
Read The Rest:economictimes...